Table 3.
Treatment regimens and clinical outcomes of patients with inflammatory bowel disease.
| Treatment regimens and outcomes | Total IBD (N = 190) |
CD (n = 80) |
UC (n = 110) |
p value |
|---|---|---|---|---|
| 5-ASAs, n (%) | 184 (96.8) | 75 (93.8) | 109 (99.1) | 0.038 |
| Corticosteroids, n (%) | 132 (69.5) | 64 (80.0) | 68 (61.8) | 0.007 |
| Immunomodulators, n (%) | 81 (42.6) | 51 (63.8) | 30 (27.3) | <0.001 |
| Biologic agents, n (%) | 115 (60.5) | 68 (85.0) | 47 (42.7) | <0.001 |
| Bowel resection, n (%) | 35 (18.4) | 31 (38.8) | 4 (3.6) | <0.001 |
| Avascular necrosis of the hips, n (%) | 6 (3.2) | 3 (3.8) | 3 (2.7) | 0.484 |
Abbreviations: 5-ASAs: 5-aminosalicylic acids; CD: Crohn's disease; IBD: inflammatory bowel disease; UC: ulcerative colitis.